Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients.
Purpose. Current literature on clinical controversies surrounding the use of thrombolytic agents in patients with intermediate-risk pulmonary embolism (PE) is reviewed. Summary. PE is a major cause of morbidity and mortality. When used in conjunction with anticoagulation, thrombolysis has been shown...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 75; no. 17; pp. 1275 - 1286 |
|---|---|
| Autores principales: | , , , , |
| Formato: | algorithm review tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
9/1/2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |